Your browser doesn't support javascript.
loading
Discovery of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor: Scaffold hopping approach.
Ledneczki, István; Tapolcsányi, Pál; Gábor, Eszter; Visegrády, András; Vass, Márton; Éles, János; Holm, Patrik; Horváth, Anita; Pocsai, Anikó; Mahó, Sándor; Greiner, István; Krámos, Balázs; Béni, Zoltán; Kóti, János; Káncz, Anna E; Thán, Márta; Kolok, Sándor; Laszy, Judit; Balázs, Ottilia; Bugovits, Gyula; Nagy, József; Vastag, Mónika; Szájli, Ágota; Bozó, Éva; Lévay, György; Lendvai, Balázs; Némethy, Zsolt.
Afiliación
  • Ledneczki I; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary. Electronic address: ledneczki@richter.hu.
  • Tapolcsányi P; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Gábor E; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Visegrády A; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Vass M; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Éles J; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Holm P; Orion Pharma, Turku, Finland.
  • Horváth A; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Pocsai A; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Mahó S; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Greiner I; Research Management, Gedeon Richter Plc., Budapest, Hungary.
  • Krámos B; Spectroscopic Research Department, Gedeon Richter Plc., Budapest, Hungary.
  • Béni Z; Spectroscopic Research Department, Gedeon Richter Plc., Budapest, Hungary.
  • Kóti J; Spectroscopic Research Department, Gedeon Richter Plc., Budapest, Hungary.
  • Káncz AE; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Thán M; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Kolok S; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Laszy J; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Balázs O; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Bugovits G; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Nagy J; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Vastag M; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Szájli Á; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Bozó É; Department of Chemistry, Gedeon Richter Plc., Budapest, Hungary.
  • Lévay G; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Lendvai B; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
  • Némethy Z; Pharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Eur J Med Chem ; 214: 113189, 2021 Mar 15.
Article en En | MEDLINE | ID: mdl-33540354
ABSTRACT
The paper focuses on the scaffold hopping-based discovery and characterization of novel nicotinic alpha 7 receptor positive modulator (α7 nAChR PAM) ligands around the reference molecule (A-867744). First, substantial efforts were carried out to assess the importance of the various pharmacophoric elements on the in vitro potency (SAR evaluation) by chemical modifications. Subsequently, several new derivatives with versatile, heteroaromatic central cores were synthesized and characterized. A promising, pyrazole-containing new chemotype with good physicochemical and in vitro parameters was identified. Retrospective analysis based on homology modeling was also carried out. Besides its favorable in vitro characteristics, the most advanced derivative 69 also showed in vivo efficacy in a rodent model of cognition (scopolamine-induced amnesia in the mouse place recognition test) and acceptable pharmacokinetic properties. Based on the in vivo data, the resulting molecule with advanced drug-like characteristics has the possibility to improve cognitive performance in a biologically relevant dose range, further strengthening the view of the supportive role of α7 nACh receptors in the cognitive processes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Agonistas Nicotínicos / Descubrimiento de Drogas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Eur J Med Chem Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Agonistas Nicotínicos / Descubrimiento de Drogas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Eur J Med Chem Año: 2021 Tipo del documento: Article
...